Why the study?
Does repeat testing at 3 months improve the accuracy of CKD prevalence estimation and associated cardiovascular risk assessment in presumed healthy volunteers?
Does repeat testing at 3 months improve the accuracy of CKD prevalence estimation and associated cardiovascular risk assessment in presumed healthy volunteers?
Repeat testing for CKD at 3 months is essential to accurately identify true CKD and its associated elevated cardiovascular risk, avoiding overdiagnosis from a single test.
No takes yet. Share an insight, caveat, or question.
Confirmed CKD on repeat testing flags higher CV risk; supports refined risk estimates in cohorts but leaves practice change open.
Brook et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: